2 unchanged sentences
and Section 16 Officers
−Removed: During the three months ended March 31, 2024,
−Removed: none of the Company’s directors or Section 16 officers adopted or terminated any contract, instruction or written plan for the purchase
+Added: During the three months ended June 30, 2024, none
+Added: of the Company’s directors or Section 16 officers adopted or terminated any contract, instruction or written plan for the purchase
or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or
any “non-Rule 10b5-1 trading arrangement”.
−Removed: NeuroOne Medical Technologies
Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
Certificate of Amendment to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K filed on March 31, 2021).
−Removed: Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
+Added: Amended and Restated Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K filed on June 21, 2024).
+Added: First Amendment to Lease
+Added: Agreement, dated May 20, 2024, by and between Biynah Cleveland, LLC, BIP Cleveland LLC, Edenvale Investors, LLC and the Company.
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
Documents are furnished not filed.
−Removed: NeuroOne Medical Technologies
+Added: Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
+Added: A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.
+Added: Certain portions of the exhibits that are not material have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
+Added: Copies of the unredacted exhibits will be furnished to the SEC upon request.
+Added: NeuroOne Medical Technologies Corporation
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 14, 2024
NeuroOne Medical Technologies Corporation
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.